Полидигидроксифенилентиосульфонат натрия - analogs
Components: Polydihydroxyphenylenethiosulfonate sodium |
|||||||||
Pharmgroups: Antihypoxants and antioxidants |
|||||||||
| Prices in pharmacies: — Instructions Полидигидроксифенилентиосульфонат натрия | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | Hypoxenum | 6.8-8.7€ |
| ≈100% | Hypoxen solution for injections | — |
| ≈100% | Hypoxeni tablets | — |
| ≈100% | Olyphenum | — |
| ≈100% | Oliphen tablets | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 54% 1.6-3.7€ Kudesan for children [Ubidecarenone]
- 47% — Oxygenum [Oxygen]
- 43% — Elcar solution [Levocarnitine]
- 43% — Kudevite [Ubidecarenone and more 1Silicium dioxide colloidal]
- 42% 2.8-7.9€ Elcar [Levocarnitine]
- 35% 17-18.9€ Cytochrome C [Cytochrome C]
- 30% 3.7-15.7€ Evrin [Ethylmethylhydroxypyridine succinate]
- 30% — Valeocor-Q10 [Ubidecarenone]
- 30% 2.7-4.1€ МетуцинВел [Ethylmethylhydroxypyridine succinate]
- 29% 2.7-4€ Dimephosphon [Dimethyloxobutylphosphonylmethylate]
- 28% 2-12.9€ Neurox [Ethylmethylhydroxypyridine succinate]
- 28% 1.6-3.9€ Medomexi [Ethylmethylhydroxypyridine succinate]
- 28% — Проинин [Ethylmethylhydroxypyridine succinate]
- 28% 1.6-2.3€ Cerecard [Ethylmethylhydroxypyridine succinate]
- 28% — Neurocard [Ethylmethylhydroxypyridine succinate]
- 27% — Levocarnitine [Levocarnitine]
- 27% — Lamivit [Retinol]
- 27% 2.8-3.4€ ЦИТОРЕАН [Ethylmethylhydroxypyridine succinate]
- 27% — Армадин лонг [Ethylmethylhydroxypyridine succinate]
- 27% — Mexidant [Ethylmethylhydroxypyridine succinate]
- 26% — Carnifit [Levocarnitine]
- 24% 9.2-9.8€ Phenotropil [Fonturacetam]
- 24% 22.7-32.9€ БРЕЙНМАКС [Meldonium+Ethylmethylhydroxypyridine succinate and more 2Meldonium, Ethylmethylhydroxypyridine succinate]
- 23% — Preductal [Trimetazidine]
- 23% — Panagen [Sodium deoxyribonucleate]
- 23% — Натрия дезоксирибонуклеат [Sodium deoxyribonucleate]
- 23% — Cardioxipin [Methylethylpiridinol and more 1Emoxipine]
- 23% — Natrium deoxyribonucleate (a acipenser lac) [Sodium deoxyribonucleate]
- 22% 0.9€ Azithromycin Macleods [Azithromycin]
- 22% 0.7-7.9€ Mexicor [Ethylmethylhydroxypyridine succinate]
- 22% 1.6-5.4€ Dihydroquercitin [Dihydroquercetin]
- 22% 2.6-2.9€ Azithromycin Sanofi [Azithromycin]
- 22% — Desoxynatum [Sodium deoxyribonucleate]
- 22% — Phosphaden tablets [Adenosine phosphate]
- 22% — Fenosanic acid [Phenosanic acid]
- 21% — Zithromycin [Azithromycin]
- 21% 0.2-11.2€ Cefotaxime [Cefotaxime]
- 21% 2-2.3€ Азитромицин-Акрихин [Azithromycin]
- 21% 1.2€ Cefuroxime [Cefuroxime]
- 21% 3.9€ Азитромицин ЭКСПРЕСС [Azithromycin]
- 21% — Азитромивел [Azithromycin]
- 21% 1.3€ Sumamox [Azithromycin]
- 21% — Азитромицин форте-алиум [Azithromycin]
- 21% — Azithromycin Renewal [Azithromycin]
- 20% 2.4-3.8€ Нейромексол [Ethylmethylhydroxypyridine succinate]
- 20% 6.8-8.5€ Актитропил [Fonturacetam]
- 20% — Erbisol
- 20% 1.9-3.1€ Акримекс [Ethylmethylhydroxypyridine succinate]
- 20% 0.4-3.8€ Азитромицин Велфарм [Azithromycin]
- 20% — Oritax [Cefotaxime]
Learn more about the selection of analogues
- The drug has «Полидигидроксифенилентиосульфонат натрия» 5 full analogs, the cheapest - Hypoxenum (6.8-8.7€); 51 analog by action, the most similar - Kudesan for children (1.6-3.7€).
- Medical online service has selected the best substitutes for Полидигидроксифенилентиосульфонат натрия based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Полидигидроксифенилентиосульфонат натрия to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.